Herantis Pharma Plc.
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease (NCT06659562) | Herantis Pharma Plc. | 2024-09-23 |
| Single Ascending Doses of HER-096 in Healthy Subjects (NCT05915247) | Herantis Pharma Plc. | 2023-03-29 |
| Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study (NCT03775538) | Herantis Pharma Plc. | 2018-07-05 |
| Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE) (NCT03658967) | Herantis Pharma Plc. | 2018-06-07 |
| Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease (NCT03295786) | Herantis Pharma Plc. | 2017-09-26 |
Track Herantis Pharma Plc. automatically
Every clearance here is in the API, with alerts when new ones post.